Glen Kacher’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.2M Buy
1,312,755
+671,830
+105% +$8.88M 2.12% 18
2026
Q1
$8.83M Buy
640,925
+148,170
+30% +$2.23M 1.65% 17
2025
Q4
$8.88M Buy
492,755
+135,000
+38% +$2.42M 1.37% 19
2025
Q3
$6.63M Sell
357,755
-195,000
-35% -$3.06M 1.12% 20
2025
Q2
$8.84M Sell
552,755
-5,000
-0.9% -$89.1K 1.81% 16
2025
Q1
$10.8M Sell
557,755
-20,480
-4% -$431K 3.03% 13
2024
Q4
$12.7M Sell
578,235
-230,000
-28% -$4.43M 2.34% 19
2024
Q3
$13.6M Buy
808,235
+323,269
+67% +$4.8M 3.22% 15
2024
Q2
$5.8M Sell
484,966
-250,000
-34% -$2.79M 1.33% 20
2024
Q1
$8.14M Sell
734,966
-55,000
-7% -$561K 1.97% 18
2023
Q4
$6.84M Sell
789,966
-1,267,833
-62% -$9.85M 2.05% 17
2023
Q3
$15.7M Sell
2,057,799
-64,955
-3% -$488K 4.63% 10
2023
Q2
$15.3M Sell
2,122,754
-720,371
-25% -$4.2M 4.05% 13
2023
Q1
$17.3M Sell
2,843,125
-1,201,202
-30% -$6.51M 4.22% 11
2022
Q4
$17.6M Sell
4,044,327
-2,617,816
-39% -$11.7M 6.57% 5
2022
Q3
$26.1M Sell
6,662,143
-100,543
-1% -$504K 6.64% 3
2022
Q2
$34.5M Sell
6,762,686
-32,314
-0.5% -$168K 2.81% 7
2022
Q1
$43.5M Hold
6,795,000
2.82% 14
2021
Q4
$54.5M Hold
6,795,000
3.26% 10
2021
Q3
$62.9M Buy
+6,795,000
New +$71M 3.16% 8

Other funds holding CLBT

Glen Kacher's CLBT Position: Q2 2026 in Review

Glen Kacher increased its Cellebrite (CLBT) stake by 105% in Q2 2026, buying an estimated $8.88M and bringing the position to 1,312,755 shares worth $19.2M. The position accounts for 2.12% of the portfolio, ranked #18.

Glen Kacher first reported a position in CLBT in Q3 2021 and has held it in 20 quarters since. The position peaked at $62.9M in Q3 2021. 200 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Glen Kacher held 1,312,755 shares of Cellebrite worth $19.2M as of Q2 2026.
  • Glen Kacher bought 671,830 Cellebrite shares in Q2 2026, an estimated $8.88M.
  • Cellebrite made up 2.12% of Glen Kacher's portfolio in Q2 2026, its #18 holding.
  • Glen Kacher first reported a position in Cellebrite in Q3 2021 and has held it in 20 quarters since.
  • Glen Kacher's Cellebrite position peaked at $62.9M in Q3 2021.
  • 200 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Light Street Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.